NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease

NCT05579236

Active Not RecruitingN/A

Sponsor: University Hospital Southampton NHS Foundation Trust

Conditions: Mild Cognitive Impairment, Alzheimer Disease, Dementia

Countries: United Kingdom

The aim of this study is to find out whether a new image analysis technique called Cortical Disarray Measurement (CDM) could be used to help better diagnose Alzheimer's disease. This study will see whether changes on CDM can be used to identify Alzheimer's disease from a group of people living with memory and thinking problems. The study will also explore how CDM relates to changes in memory or thinking over time.

Eligibility overview

Sex: ALL

Age: 50 Years to 90 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
PATIENT PARTICIPANTS

Inclusion Criteria:

* Diagnosis of mild cognitive impairment (MCI) or prodromal Alzheimer's Disease (AD) as defined by National Institute on Ageing/Alzheimer's Association (NIA/AA) diagnostic criteria for MCI/prodromal AD, NOT including MCI unlikely due to AD; OR, Diagnosis of Alzheimer's disease as defined by NIA/AA criteria for probable AD
* Clinical dementia rating (CDR) scale global score of very mild or mild (0.5 or 1) impairment
* Ability to undergo and tolerate MRI scans, with no contraindications to MRI
* Ability to tolerate blood draws
* Ability to give informed consent to participate in the study

Exclusion Criteria:

* Do not meet the inclusion criteria
* No study companion available
* Individuals with a non-progressive learning disability
* Pregnant or intending to become pregnant during the study

COMPANION PARTICIPANTS

Inclusion Criteria:

* Aged over 18 years
* Sufficient knowledge on study participant's condition to complete companion assessments of the patient, in the investigator's judgement
* Able and willing to attend all clinical visits for completion of companion assessments or provide the relevant assessments remotely via phone or video call

Exclusion Criteria:

* A condition or reason, in the investigator's judgement, that would question the validity of the acquired companion reported data
* Individuals who are not fluent in English
Locations (3)
  • Southampton, Hampshire, United Kingdom
  • Bournemouth, United Kingdom
  • Cardiff, United Kingdom